Explore insights by topic
All insights 2
Article Drug pipeline
Managed Care Implications of Fixed-Duration Lenalidomide Maintenance in Multiple Myeloma (MM)
Is Shorter Duration Therapy Less Effective Than Indefinite Maintenance? The phase 3 ENDURANCE (E1A11) trial provides compelling evidence regarding the duration of lenalidomide maintenance in patients…
Read the articleArticle Precision medicine
Minimal Residual Disease in Oncology
Minimal residual disease (MRD) testing has become one of the most important advances in cancer care over the past twenty years. It can find very small…
Read the article

